Skip to main content

Advertisement

SpringerLink
Log in

Risk of overactive bladder after hysterectomy for uterine fibroids

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

We evaluated the association between previous hysterectomy for uterine fibroids and the risk of developing overactive bladder (OAB).

Methods

We used national health insurance data. The hysterectomy group (aged 40 to 59) comprised patients who underwent hysterectomy for uterine leiomyoma or adenomyosis between 1 January 2011 and 31 December 2014, and the control group (aged 40 to 59) comprised patients who visited a medical facility for a checkup during the same time period. Propensity score matching (PSM, 1:1) was performed to balance confounders. OAB events were defined by drug prescriptions (beta 3 agonist or anticholinergics) for more than 1 month based on previous studies.

Results

After matching, 58,195 cases (hysterectomy group) and 58,195 controls (nonhysterectomy group) were enrolled. The mean follow-up period was 7.9 years in the nonhysterectomy group and 8.0 years in the hysterectomy group. There was no significant difference in the rate of OAB development between the groups (0.3% vs 0.3%; p=0.061). Additionally, compared with the nonhysterectomy group (hazard ratio: 1 (reference)), hysterectomy without adnexal surgery (hazard ratio: 1.169 [0.915–1.493]) and hysterectomy with adnexal surgery (hazard ratio: 1.342 [0.83–2.171]) did not significantly increase the risk of OAB after adjusting for confounders; this relationship remained nonsignificant after stratifying patients according to age group.

Conclusions

Previous hysterectomy with or without adnexal surgery for the treatment of uterine fibroids did not increase the risk of developing OAB, defined as drug therapy lasting more than 1 month.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000.

    Article  PubMed  Google Scholar 

  2. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–15.

    Article  PubMed  Google Scholar 

  3. Lin X-D, Lin N, Ke Z-B, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine. 2021;100(20);e25761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Raju R, Linder BJ. Evaluation and treatment of overactive bladder in women. Mayo Clin Proc. 2020;95(2):370–7.

    Article  PubMed  Google Scholar 

  5. Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. 2003;326(7394):841.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54(3):543–62.

    Article  CAS  PubMed  Google Scholar 

  7. Solifenacin and darifenacin for overactive bladder. Obstet Gynecol. 2005;106(2):401–2. https://doi.org/10.1097/01.AOG.0000173816.33966.ed.

  8. Thomas TN, Walters MD. AUGS consensus statement: association of anticholinergic medication use and cognition in women with overactive bladder. Female Pelvic Med Reconstr Surg. 2017;23(3):177–8.

    Article  Google Scholar 

  9. Wang J, Zhou Z, Cui Y, et al. Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder. Neurourol Urodyn. 2019;38(1):22–30.

    Article  PubMed  Google Scholar 

  10. Acar Ö, Erton ML, Tarcan T. Insights into the management of overactive bladder: what difference can mirabegron make? J Urol Surg. 2019;6(2):85.

    Article  Google Scholar 

  11. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.

    Article  PubMed  Google Scholar 

  12. Lee M, Chung Y-J, Kim H-K, et al. Estimated prevalence and incidence of uterine leiomyoma, and its treatment trend in south Korean women for 12 years: a national population-based study. J Womens Health. 2021;30(7):1038–46.

    Article  Google Scholar 

  13. Vilos GA, Allaire C, Laberge P-Y, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–78.

    Article  PubMed  Google Scholar 

  14. Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication—a systematic review. J Clin Med. 2021;10(22):5335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Li P-C, Huang H-K, Ding D-C. Hysterectomy associated with de novo lower urinary tract symptoms in a Taiwanese population: a nationwide, population-based study. Int Urogynecol J. 2019;30(10):1711–7.

    Article  PubMed  Google Scholar 

  16. Selcuk S, Cam C, Asoglu MR, et al. Effect of simple and radical hysterectomy on quality of life–analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84–8.

    Article  PubMed  Google Scholar 

  17. Berujon E, Thubert T, Fauvet R, Villot A, Pizzoferrato A-C. Impact of uterine fibroid surgery on lower urinary tract symptoms. J Gynecol Obstet Human Reprod. 2022;51(5):102355.

    Article  Google Scholar 

  18. Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM II, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1–12.

    Article  PubMed  Google Scholar 

  19. Altman D, López A, Falconer C, Zetterström J. The impact of hysterectomy on lower urinary tract symptoms. Int Urogynecol J. 2003;14(6):418–23.

    Article  Google Scholar 

  20. Kim L, Kim J-A, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause. 2020;27(2):238.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hwang S, Kang SW, Choi KJ, et al. Early menopause is associated with increased risk of retinal vascular occlusions: a nationwide cohort study. Sci Rep. 2022;12(1):1–10.

    Article  CAS  Google Scholar 

  23. Li J-R, Wang S-S, Lin C-H, De Groat WC, Cheng C-L. Positive association of male overactive bladder symptoms and androgen deprivation: a nationwide population-based cohort study. Anticancer Res. 2019;39(1):305–11.

    Article  PubMed  Google Scholar 

  24. Cheng C-L, Li J-R, Lin C-H, de Groat WC. Positive association of female overactive bladder symptoms and estrogen deprivation: a nationwide population-based cohort study in Taiwan. Medicine. 2016;95(28):e4107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Haab F, Castro-Diaz D. Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Pract. 2005;59(8):931–7.

    Article  CAS  PubMed  Google Scholar 

  26. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.

    Article  PubMed  Google Scholar 

  27. Iosif CS, Batra S, Ek A, Åstedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981;141(7):817–20.

    Article  CAS  PubMed  Google Scholar 

  28. Versi E, Harvey M-A, Cardozo L, Brincat M, Studd J. Urogenital prolapse and atrophy at menopause: a prevalence study. Int Urogynecol J. 2001;12(2):107–10.

    Article  CAS  Google Scholar 

  29. DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992;166(6):1717–28.

    Article  CAS  PubMed  Google Scholar 

  30. Maas CP, Kenter GG, Trimbos JB, Deruiter MC. Anatomical basis for nerve-sparing radical hysterectomy: immunohistochemical study of the pelvic autonomic nerves. Acta Obstet Gynecol Scand. 2005;84(9):868–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Sanggye Paik Hospital, School of Medicine, Inje University, Seoul, Republic of Korea

    Jin-Sung Yuk

  2. Department of Urology, Nowon Eulji Medical Center, Eulji University School of Medicine, 327, Gongneung-ro, Nowon-gu, Seoul, 01830, South Korea

    Jun Ho Lee

Authors
  1. Jin-Sung Yuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Ho Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Ho Lee.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 12 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuk, JS., Lee, J.H. Risk of overactive bladder after hysterectomy for uterine fibroids. Int Urogynecol J 34, 1823–1829 (2023). https://doi.org/10.1007/s00192-023-05474-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-023-05474-9

Keywords

Search

Navigation